Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine
about
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammationHIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathyHuman CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementiaEstrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaineGonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanismRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesCortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersInteraction of paroxetine with mitochondrial proteins mediates neuroprotection.HIV and antiretroviral therapy in the brain: neuronal injury and repairAnxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat.The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response.Neonatal intrahippocampal gp120 injection: an examination early in development.Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measuresPharmacodynamics of memantine: an update.Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsNuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat proteinGp120 in the pathogenesis of human immunodeficiency virus-associated pain.Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportIbudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cellsAging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseThinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia.Memantine for AIDS dementia complex: open-label report of ACTG 301.The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesEnvelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathwaysHIV neurotoxicity: potential therapeutic interventionsHIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND).Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS.Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Investigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation.Novel mechanisms of central nervous system damage in HIV infection.Eradication of human immunodeficiency virus from brain reservoirs.Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA [corrected].
P2860
Q21129283-2FB81EDA-B267-49A7-B9EA-596158D13773Q24563955-B16735A0-DF12-4E4B-A07A-D879E28D7F9EQ24794489-3424D7B4-E646-4E81-928D-B5A3638E116CQ24796371-F0B26443-3BD6-4DE4-84EF-A571F0B925FAQ24813383-C48CB5D3-57B2-4A54-A7CC-06F9F374FB9EQ26829535-5CBB6C21-847C-4E09-927A-BA468D7831C8Q27013928-AAD29E94-4221-45D6-9908-038EB1A96C5FQ27025573-89EA2A6A-AD87-4ECD-81C0-913BD346AB19Q27339182-00781DD4-3DDB-4800-816D-7F819ECE0716Q28279808-4F2E0998-5415-478E-A4FC-49D8DF9A18CBQ30410538-FC8B2475-77BA-492A-906A-4DA9D8500E7CQ30411844-A5221089-0DC9-4EDC-9748-C0AE25E8E1B9Q30437301-017B66EA-71A8-40B3-990A-7E19C04FBCEFQ30452600-1A0BA193-A829-4B13-90BE-6AE979C01F61Q30486458-36BCCCB4-B154-49A5-B487-439D78B89714Q30490604-C06A307B-4167-49A3-964F-B614961A05E5Q30497248-41048F4C-30BA-4DE3-AB9E-DB5DC450EF97Q33604853-4F1F083A-EA24-47F9-9674-8FF9413A2B2FQ33605370-FBD34759-6E1C-4B5B-8CEE-FE8A59211F3FQ33614467-86C961AD-75B7-4390-BBA4-6DD95DABE56CQ33649838-A5C37684-4392-4B68-95B7-0CA67BF26805Q33786188-A139357A-606A-415E-A00B-0854C9071319Q33831637-A42E53BA-78EA-4568-A41C-18D12FB6D4FEQ33870898-B8AD374E-F29C-41DA-8712-1D0513608E93Q33873538-A51B0151-40CC-4641-8C33-3C51E212A36BQ33920647-18F15E19-AC70-48D4-83AA-C60638B92ECFQ34098327-A8F71731-568D-453F-B43B-701BFA9634C9Q34145508-47E0CA42-1F63-426C-9D23-93C9711C5A7EQ34312179-9AD96D26-F2FD-42F1-8C20-388863FD4B4BQ34329204-B599536D-8681-4B8B-94BD-6EC04C667517Q34332239-A7774B3F-A151-41F8-A34F-FA239E41F06BQ34393925-C7018D6E-1B20-4928-A42A-3DE75A328232Q34795283-AAD1E4D8-5E8F-4064-966E-0ED21692379EQ34903986-FBC459E5-2887-448F-9DCE-978024639224Q35054688-6AC35EF5-ED0D-4C43-9B53-59DF2693E114Q35215063-C149D9DA-E356-441B-985B-83C75E2244D7Q35220407-E54A0A68-B5D7-4CD5-A6A2-509244303135Q35557261-3B19E908-70CD-4F0D-8D88-4C55C25FC689Q35567289-DC272D79-6947-4C15-89AD-3E0E7C3EA702Q35574768-F877453D-4EE8-4EAE-B80F-E2E02A316267
P2860
Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@ast
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@en
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@nl
type
label
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@ast
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@en
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@nl
prefLabel
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@ast
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@en
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@nl
P2093
P3181
P1433
P1476
Synergistic neurotoxicity by h ...... gp120: protection by memantine
@en
P2093
P304
P3181
P356
10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V
P407
P577
2000-02-01T00:00:00Z